{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T19:25:46Z","timestamp":1793388346053,"version":"4.5.0"},"reference-count":251,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T00:00:00Z","timestamp":1700092800000},"content-version":"am","delay-in-days":411,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01AI073693"],"award-info":[{"award-number":["P01AI073693"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.jaut.2022.102911","type":"journal-article","created":{"date-parts":[[2022,9,18]],"date-time":"2022-09-18T09:27:03Z","timestamp":1663493223000},"page":"102911","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Cognitive dysfunction in SLE: An understudied clinical manifestation"],"prefix":"10.1016","volume":"132","author":[{"given":"Mark","family":"Mizrachi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaitlin R.","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazila","family":"Tehrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce T.","family":"Volpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3250-3804","authenticated-orcid":false,"given":"Betty","family":"Diamond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2022.102911_bib1","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1136\/ard.2008.106351","article-title":"Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosus","volume":"69","author":"Hanly","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2022.102911_bib2","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1177\/0961203318772021","article-title":"Prevalence, risk factors, and impact on mortality of neuropsychiatric lupus: a prospective, single-center study","volume":"27","author":"Ahn","year":"2018","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2022.102911_bib3","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1177\/09612033211031008","article-title":"Cognitive impairment in systemic lupus erythematosus is negatively related to social role participation and quality of life: a systematic review","volume":"30","author":"Mendelsohn","year":"2021","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2022.102911_bib4","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/1529-0131(199904)42:4<599::AID-ANR2>3.0.CO;2-F","article-title":"The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes","volume":"42","year":"1999","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2022.102911_bib5","first-page":"146","article-title":"Peripheral nervous system involvement in systemic lupus erythematosus: a review of the evidence","volume":"37","author":"Bortoluzzi","year":"2019","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jaut.2022.102911_bib6","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2021-000507","article-title":"Characteristics of cardiovascular autonomic dysfunction and association with quality of life in patients with systemic lupus erythematosus","volume":"8","author":"Zinglersen","year":"2021","journal-title":"Lupus Sci. Med."},{"key":"10.1016\/j.jaut.2022.102911_bib7","doi-asserted-by":"crossref","first-page":"E9501","DOI":"10.3390\/ijerph17249501","article-title":"Heart rate variability in women with systemic lupus erythematosus: association with health-related parameters and effects of aerobic exercise","volume":"17","author":"Mart\u00ednez-Rosales","year":"2020","journal-title":"Int. J. Environ. Res. Publ. Health"},{"key":"10.1016\/j.jaut.2022.102911_bib8","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1177\/0961203318771502","article-title":"Heart rate variability in patients with systemic lupus erythematosus: a systematic review and methodological considerations","volume":"27","author":"Matusik","year":"2018","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2022.102911_bib9","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/art.1780350310","article-title":"A revised estimate of twin concordance in systemic lupus erythematosus","volume":"35","author":"Deapen","year":"1992","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2022.102911_bib10","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/BOR.0000000000000205","article-title":"Advances in lupus genetics","volume":"27","author":"Niewold","year":"2015","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.jaut.2022.102911_bib11","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/art.20999","article-title":"Familial aggregation of systemic lupus erythematosus, rheumatoid arthritis, and other autoimmune diseases in 1,177 lupus patients from the GLADEL cohort","volume":"52","author":"Alarc\u00f3n-Segovia","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2022.102911_bib12","doi-asserted-by":"crossref","first-page":"E1180","DOI":"10.3390\/cells8101180","article-title":"Update on the genetics of systemic lupus erythematosus: genome-wide association studies and beyond","volume":"8","author":"Kwon","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.jaut.2022.102911_bib13","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41584-018-0156-8","article-title":"Neuropsychiatric lupus: new mechanistic insights and future treatment directions","volume":"15","author":"Schwartz","year":"2019","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jaut.2022.102911_bib14","doi-asserted-by":"crossref","first-page":"541","DOI":"10.3899\/jrheum.150884","article-title":"Genetic variants that are associated with neuropsychiatric systemic lupus erythematosus","volume":"43","author":"Ho","year":"2016","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jaut.2022.102911_bib15","series-title":"Syst. Lupus Erythematosus","first-page":"307","article-title":"Chapter 36 - pathogenesis of tissue injury in the brain in patients with systemic lupus erythematosus","author":"Volpe","year":"2016"},{"key":"10.1016\/j.jaut.2022.102911_bib16","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1016\/j.immuni.2021.09.014","article-title":"Microglia: immune and non-immune functions","volume":"54","author":"Borst","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2022.102911_bib17","doi-asserted-by":"crossref","first-page":"R326","DOI":"10.1016\/j.cub.2021.01.056","article-title":"Astrocytes","volume":"31","author":"Hasel","year":"2021","journal-title":"Curr. Biol."},{"key":"10.1016\/j.jaut.2022.102911_bib18","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/nri.2017.100","article-title":"Organ-specific protection mediated by cooperation between vascular and epithelial barriers","volume":"17","author":"Spadoni","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jaut.2022.102911_bib19","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1177\/0961203318804899","article-title":"Peripheral levels of brain-derived neurotrophic factor and S100B in neuropsychiatric systemic lupus erythematous","volume":"27","author":"Noris-Garcia","year":"2018","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2022.102911_bib20","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1177\/0961203317691374","article-title":"S100beta is associated with cognitive impairment in childhood-onset systemic lupus erythematosus patients","volume":"26","author":"Lapa","year":"2017","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2022.102911_bib21","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/imm.12489","article-title":"C5a alters blood\u2013brain barrier integrity in a human in vitro model of systemic lupus erythematosus","volume":"146","author":"Mahajan","year":"2015","journal-title":"Immunology"},{"key":"10.1016\/j.jaut.2022.102911_bib22","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.autrev.2017.04.008","article-title":"The blood brain barrier and neuropsychiatric lupus: new perspectives in light of advances in understanding the neuroimmune interface","volume":"16","author":"Stock","year":"2017","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2022.102911_bib23","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.semarthrit.2018.02.007","article-title":"What is the prevalence of cognitive impairment in lupus and which instruments are used to measure it? A systematic review and meta-analysis","volume":"48","author":"Al Rayes","year":"2018","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.jaut.2022.102911_bib24","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1002\/art.40933","article-title":"Cognitive dysfunction in systemic lupus erythematosus: a case for initiating trials","volume":"71","author":"Kello","year":"2019","journal-title":"Arthritis Rheumatol. (Hoboken, N.J.)"},{"key":"10.1016\/j.jaut.2022.102911_bib25","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1177\/09612033211062530","article-title":"Validation of the automated neuropsychological assessment metrics for assessing cognitive impairment in systemic lupus erythematosus","volume":"31","author":"Yuen","year":"2022","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2022.102911_bib26","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s12026-015-8716-3","article-title":"Lupus brain fog: a biologic perspective on cognitive impairment, depression, and fatigue in systemic lupus erythematosus","volume":"63","author":"Mackay","year":"2015","journal-title":"Immunol. Res."},{"key":"10.1016\/j.jaut.2022.102911_bib27","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.semarthrit.2021.05.018","article-title":"Metrics and definitions used in the assessment of cognitive impairment in systemic lupus erythematosus: a systematic review","volume":"51","author":"Yuen","year":"2021","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.jaut.2022.102911_bib28","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1002\/acr.24096","article-title":"Validity evidence for the use of automated neuropsychologic assessment metrics as a screening tool for cognitive impairment in systemic lupus erythematosus","volume":"72","author":"Tayer-Shifman","year":"2020","journal-title":"Arthritis Care Res. (Hoboken)"},{"key":"10.1016\/j.jaut.2022.102911_bib29","doi-asserted-by":"crossref","first-page":"131","DOI":"10.5114\/reum.2015.53134","article-title":"Cambridge Neuropsychological Test Automated Battery in assessment of cognitive parameters in patients with systemic lupus erythematosus in relation to autoantibody profile","volume":"53","author":"Bogaczewicz","year":"2015","journal-title":"Reumatologia"},{"key":"10.1016\/j.jaut.2022.102911_bib30","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.3899\/jrheum.161125","article-title":"Performance of screening tests for cognitive impairment in systemic lupus erythematosus","volume":"44","author":"Nantes","year":"2017","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jaut.2022.102911_bib31","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s41927-022-00253-3","article-title":"Cognitive performance in systemic lupus erythematosus patients: a cross-sectional and longitudinal study","volume":"6","author":"Langensee","year":"2022","journal-title":"BMC Rheumatol."},{"key":"10.1016\/j.jaut.2022.102911_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0196103","article-title":"Cognitive dysfunction improves in systemic lupus erythematosus: results of a 10 years prospective study","volume":"13","author":"Ceccarelli","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2022.102911_bib33","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.124002","article-title":"Metabolic and microstructural alterations in the SLE brain correlate with cognitive impairment","volume":"4","author":"Mackay","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.jaut.2022.102911_bib34","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.ebiom.2015.05.027","article-title":"Selective impairment of spatial cognition caused by autoantibodies to the N-Methyl-D-Aspartate receptor","volume":"2","author":"Chang","year":"2015","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jaut.2022.102911_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2021.102637","article-title":"Quantitative susceptibility mapping in the thalamus and basal ganglia of systemic lupus erythematosus patients with neuropsychiatric complaints","volume":"30","author":"Bulk","year":"2021","journal-title":"NeuroImage Clin."},{"key":"10.1016\/j.jaut.2022.102911_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2021.577518","article-title":"Neuropathological spectrum in systemic lupus erythematosus: a single institute autopsy experience","volume":"353","author":"Thirunavukkarasu","year":"2021","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jaut.2022.102911_bib37","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00062-015-0397-8","article-title":"Global cognitive impairment in systemic lupus erythematosus patients: a structural MRI study","volume":"27","author":"Zimmermann","year":"2017","journal-title":"Clin. Neuroradiol."},{"key":"10.1016\/j.jaut.2022.102911_bib38","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1177\/0961203317691373","article-title":"Magnetic resonance imaging in neuropsychiatric systemic lupus erythematosus: current state of the art and novel approaches","volume":"26","author":"Postal","year":"2017","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2022.102911_bib39","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.autrev.2017.11.008","article-title":"Brain diffusion tensor MRI in systematic lupus erythematosus: a systematic review","volume":"17","author":"Costallat","year":"2018","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2022.102911_bib40","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13075-018-1516-0","article-title":"Altered white matter microstructure in lupus patients: a diffusion tensor imaging study","volume":"20","author":"Nystedt","year":"2018","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2022.102911_bib41","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1177\/1971400918793601","article-title":"White-matter integrity in patients with systemic lupus erythematosus and memory deficits","volume":"31","author":"Corr\u00eaa","year":"2018","journal-title":"NeuroRadiol. J."},{"key":"10.1016\/j.jaut.2022.102911_bib42","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1177\/0961203318793215","article-title":"Longitudinal evaluation of diffusion tensor imaging and cognition in systemic lupus erythematosus","volume":"27","author":"Kozora","year":"2018","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2022.102911_bib43","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/1529-0131(199901)42:1<61::AID-ANR8>3.0.CO;2-9","article-title":"Discrepancy between regional cerebral blood flow and glucose metabolism of the brain in systemic lupus erythematosus patients with normal brain magnetic resonance imaging findings","volume":"42","author":"Kao","year":"1999","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2022.102911_bib44","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/ard.59.5.377","article-title":"Diagnosis and monitoring of central nervous system involvement in systemic lupus erythematosus: value of F-18 fluorodeoxyglucose PET","volume":"59","author":"Weiner","year":"2000","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2022.102911_bib45","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1212\/WNL.40.2.304","article-title":"Positron emission tomography in neuropsychiatric lupus erythematosus","volume":"40","author":"Stoppe","year":"1990","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2022.102911_bib46","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1159\/000008067","article-title":"Decreased regional cerebral metabolic rate for glucose in systemic lupus erythematosus patients with psychiatric symptoms","volume":"42","author":"Komatsu","year":"1999","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.jaut.2022.102911_bib47","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1177\/0961203312459104","article-title":"The efficacy of brain (18)F-fluorodeoxyglucose positron emission tomography in neuropsychiatric lupus patients with normal brain magnetic resonance imaging findings","volume":"21","author":"Lee","year":"2012","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2022.102911_bib48","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jns.2017.05.059","article-title":"Regional cerebral glucose metabolism in systemic lupus erythematosus patients with major depressive disorder","volume":"379","author":"Saito","year":"2017","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jaut.2022.102911_bib49","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1002\/art.30458","article-title":"Neuroimaging evidence of white matter inflammation in newly diagnosed systemic lupus erythematosus","volume":"63","author":"Ramage","year":"2011","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2022.102911_bib50","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2014-000074","article-title":"Brain metabolism and autoantibody titres predict functional impairment in systemic lupus erythematosus","volume":"2","author":"Mackay","year":"2015","journal-title":"Lupus Sci. Med."},{"key":"10.1016\/j.jaut.2022.102911_bib51","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/WCO.0000000000000822","article-title":"Advanced neuroimaging in neuropsychiatric systemic lupus erythematosus","volume":"33","author":"Mackay","year":"2020","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.jaut.2022.102911_bib52","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1038\/jcbfm.2014.85","article-title":"Regional brain metabolism in a murine systemic lupus erythematosus model","volume":"34","author":"Vo","year":"2014","journal-title":"J. Cereb. Blood Flow Metab. Off. J. Int. Soc. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.jaut.2022.102911_bib53","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.pharmthera.2018.09.003","article-title":"TSPO in diverse CNS pathologies and psychiatric disease: a critical review and a way forward","volume":"194","author":"Guilarte","year":"2019","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jaut.2022.102911_bib54","doi-asserted-by":"crossref","first-page":"E993","DOI":"10.3390\/ijms18050993","article-title":"Molecular imaging of neuroinflammation in neurodegenerative dementias: the role of in vivo PET imaging","volume":"18","author":"Cerami","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jaut.2022.102911_bib55","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1177\/0961203316657432","article-title":"Neuroimaging of translocator protein in patients with systemic lupus erythematosus: a pilot study using [11C]DPA-713 positron emission tomography","volume":"26","author":"Wang","year":"2017","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2022.102911_bib56","doi-asserted-by":"crossref","first-page":"677","DOI":"10.3389\/fpsyt.2018.00677","article-title":"A conscious resting state fMRI study in SLE patients without major neuropsychiatric manifestations","volume":"9","author":"Liu","year":"2018","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.jaut.2022.102911_bib57","doi-asserted-by":"crossref","first-page":"5225","DOI":"10.1007\/s12035-016-0050-9","article-title":"Decreased coupling between functional connectivity density and amplitude of low frequency fluctuation in non-neuropsychiatric systemic lupus erythematosus: a resting-stage functional MRI study","volume":"54","author":"Zhang","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.jaut.2022.102911_bib58","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1089\/brain.2017.0557","article-title":"Functional connectivity changes in systemic lupus erythematosus: a resting-state study","volume":"8","author":"Nystedt","year":"2018","journal-title":"Brain Connect."},{"key":"10.1016\/j.jaut.2022.102911_bib59","doi-asserted-by":"crossref","first-page":"3634","DOI":"10.1038\/s41380-020-00907-z","article-title":"Resting state network functional connectivity abnormalities in systemic lupus erythematosus: correlations with neuropsychiatric impairment","volume":"26","author":"Bonacchi","year":"2021","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.jaut.2022.102911_bib60","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1146\/annurev-neuro-071013-014030","article-title":"The brain's default mode network","volume":"38","author":"Raichle","year":"2015","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.jaut.2022.102911_bib61","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/9408612","article-title":"Altered amplitude of low-frequency fluctuations in inactive patients with nonneuropsychiatric systemic lupus erythematosus","volume":"2019","author":"Yu","year":"2019","journal-title":"Neural Plast."},{"key":"10.1016\/j.jaut.2022.102911_bib62","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00234-018-2138-6","article-title":"Abnormal amplitude of low frequency fluctuation and functional connectivity in non-neuropsychiatric systemic lupus erythematosus: a resting-state fMRI study","volume":"61","author":"Yu","year":"2019","journal-title":"Neuroradiology"},{"key":"10.1016\/j.jaut.2022.102911_bib63","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1002\/hbm.21158","article-title":"Localization of cerebral functional deficits in patients with non-neuropsychiatric systemic lupus erythematosus","volume":"32","author":"Lin","year":"2011","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.jaut.2022.102911_bib64","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1007\/s11682-017-9729-4","article-title":"Cortical thickness reductions associate with abnormal resting-state functional connectivity in non-neuropsychiatric systemic lupus erythematosus","volume":"12","author":"Niu","year":"2018","journal-title":"Brain Imaging Behav."},{"key":"10.1016\/j.jaut.2022.102911_bib65","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3899\/jrheum.160290","article-title":"Spatial working memory impairment in patients with non-neuropsychiatric systemic lupus erythematosus: a blood-oxygen-level dependent functional magnetic resonance imaging study","volume":"44","author":"Zhu","year":"2017","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jaut.2022.102911_bib66","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1002\/cne.24656","article-title":"Functional connectivity changes in core resting state networks are associated with cognitive performance in systemic lupus erythematosus","volume":"527","author":"Nystedt","year":"2019","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.jaut.2022.102911_bib67","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1177\/0961203313480399","article-title":"Learning and memory-related brain activity dynamics are altered in systemic lupus erythematosus: a functional magnetic resonance imaging study","volume":"22","author":"Shapira-Lichter","year":"2013","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2022.102911_bib68","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1002\/acr.22873","article-title":"Functional magnetic resonance imaging of working memory and executive dysfunction in systemic lupus erythematosus and antiphospholipid antibody-positive patients","volume":"68","author":"Kozora","year":"2016","journal-title":"Arthritis Care Res. (Hoboken)"},{"key":"10.1016\/j.jaut.2022.102911_bib69","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0074530","article-title":"Abnormalities of frontal-parietal resting-state functional connectivity are related to disease activity in patients with systemic lupus erythematosus","volume":"8","author":"Hou","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2022.102911_bib70","doi-asserted-by":"crossref","first-page":"4048","DOI":"10.1002\/art.34660","article-title":"Dysfunctional cortico-basal ganglia-thalamic circuit and altered hippocampal-amygdala activity on cognitive set-shifting in non-neuropsychiatric systemic lupus erythematosus","volume":"64","author":"Ren","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2022.102911_bib71","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1177\/0961203315593819","article-title":"Cognitive dysfunction and functional magnetic resonance imaging in systemic lupus erythematosus","volume":"24","author":"Barraclough","year":"2015","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2022.102911_bib72","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1136\/annrheumdis-2018-214677","article-title":"Altered cognitive function in systemic lupus erythematosus and associations with inflammation and functional and structural brain changes","volume":"78","author":"Barraclough","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2022.102911_bib73","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.semarthrit.2011.11.010","article-title":"A prospective functional MRI study for executive function in patients with systemic lupus erythematosus without neuropsychiatric symptoms","volume":"41","author":"Mak","year":"2012","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.jaut.2022.102911_bib74","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1093\/brain\/aww031","article-title":"Glial and axonal changes in systemic lupus erythematosus measured with diffusion of intracellular metabolites","volume":"139","author":"Ercan","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.jaut.2022.102911_bib75","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1002\/art.27458","article-title":"The histopathologic associates of neurometabolite abnormalities in fatal neuropsychiatric systemic lupus erythematosus","volume":"62","author":"Brooks","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2022.102911_bib76","first-page":"408","article-title":"Dynamic contrast-enhanced MRI reveals unique blood-brain barrier permeability characteristics in the Hippocampus in the normal brain","volume":"40","author":"Ivanidze","year":"2019","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.jaut.2022.102911_bib77","first-page":"E67","article-title":"Reply, AJNR","volume":"40","author":"Ivanidze","year":"2019","journal-title":"Am. J. Neuroradiol."},{"key":"10.1016\/j.jaut.2022.102911_bib78","first-page":"470","article-title":"Alterations in blood-brain barrier permeability in patients with systemic lupus erythematosus","volume":"40","author":"Chi","year":"2019","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.jaut.2022.102911_bib79","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1136\/annrheumdis-2020-218004","article-title":"Blood-brain barrier leakage in systemic lupus erythematosus is associated with gray matter loss and cognitive impairment","volume":"79","author":"Kamintsky","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2022.102911_bib80","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/acr.22923","article-title":"Altered blood-brain barrier permeability in patients with systemic lupus erythematosus: a novel imaging approach","volume":"69","author":"Gulati","year":"2017","journal-title":"Arthritis Care Res. (Hoboken)"},{"key":"10.1016\/j.jaut.2022.102911_bib81","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1136\/annrheumdis-2017-212285","article-title":"Neuropsychiatric lupus or not? Cerebral hypoperfusion by perfusion-weighted MRI in normal-appearing white matter in primary neuropsychiatric lupus erythematosus","volume":"77","author":"Papadaki","year":"2018","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2022.102911_bib82","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1177\/0961203319887793","article-title":"Regional cerebral perfusion correlates with anxiety in neuropsychiatric SLE: evidence for a mechanism distinct from depression","volume":"28","author":"Papadaki","year":"2019","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2022.102911_bib83","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1177\/0961203319861677","article-title":"Cerebral blood flow abnormalities in neuropsychiatric systemic lupus erythematosus","volume":"28","author":"Jia","year":"2019","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2022.102911_bib84","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.3899\/jrheum.100121","article-title":"Cerebral blood flow in depressed patients with systemic lupus erythematosus","volume":"37","author":"Giovacchini","year":"2010","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jaut.2022.102911_bib85","article-title":"Inflammatory cytokines in systemic lupus erythematosus","volume":"2011","author":"Ohl","year":"2011","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.jaut.2022.102911_bib86","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.yfrne.2011.12.002","article-title":"Cytokines and brain excitability","volume":"33","author":"Galic","year":"2012","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.jaut.2022.102911_bib87","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/268436","article-title":"Cytokines and chemokines in neuropsychiatric syndromes of systemic lupus erythematosus","volume":"2010","author":"Okamoto","year":"2010","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.jaut.2022.102911_bib88","article-title":"The type I interferonopathies: 10 years on","author":"Crow","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jaut.2022.102911_bib89","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1038\/ng1842","article-title":"Mutations in genes encoding ribonuclease H2 subunits cause Aicardi-Gouti\u00e8res syndrome and mimic congenital viral brain infection","volume":"38","author":"Crow","year":"2006","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jaut.2022.102911_bib90","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1084\/jem.20151529","article-title":"Human USP18 deficiency underlies type 1 interferonopathy leading to severe pseudo-TORCH syndrome","volume":"213","author":"Meuwissen","year":"2016","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jaut.2022.102911_bib91","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.15252\/embj.201490791","article-title":"USP18 lack in microglia causes destructive interferonopathy of the mouse brain","volume":"34","author":"Goldmann","year":"2015","journal-title":"EMBO J."},{"key":"10.1016\/j.jaut.2022.102911_bib92","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0278-5846(01)00324-4","article-title":"Interferon alpha (IFNalpha) and psychiatric syndromes: a review","volume":"26","author":"Schaefer","year":"2002","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jaut.2022.102911_bib93","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s13075-019-1985-9","article-title":"Interferon-\u03b1 exacerbates neuropsychiatric phenotypes in lupus-prone mice","volume":"21","author":"Zeng","year":"2019","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2022.102911_bib94","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2220\/biomedres.38.371","article-title":"Cognitive impairment with interferon treatment in patients with chronic hepatitis C","volume":"38","author":"Tanaka","year":"2017","journal-title":"Biomed. Res."},{"key":"10.1016\/j.jaut.2022.102911_bib95","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.bbi.2015.12.011","article-title":"Interferon-\u03b1 acutely impairs whole-brain functional connectivity network architecture - a preliminary study","volume":"58","author":"Dipasquale","year":"2016","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jaut.2022.102911_bib96","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jad.2016.11.039","article-title":"Biological mechanisms of depression following treatment with interferon for chronic hepatitis C: a critical systematic review","volume":"209","author":"Machado","year":"2017","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jaut.2022.102911_bib97","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1038\/sj.npp.1301362","article-title":"Basal ganglia hypermetabolism and symptoms of fatigue during interferon-alpha therapy","volume":"32","author":"Capuron","year":"2007","journal-title":"Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.jaut.2022.102911_bib98","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1177\/0961203316629556","article-title":"IL-6, IL-8, IP-10, MCP-1 and G-CSF are significantly increased in cerebrospinal fluid but not in sera of patients with central neuropsychiatric lupus erythematosus","volume":"25","author":"Yoshio","year":"2016","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2022.102911_bib99","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.neuropharm.2016.08.003","article-title":"The kynurenine pathway and the brain: challenges, controversies and promises","volume":"112","author":"Schwarcz","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jaut.2022.102911_bib100","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/7854_2016_12","article-title":"Role of kynurenine metabolism pathway activation in major depressive disorders","volume":"31","author":"Savitz","year":"2017","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.jaut.2022.102911_bib101","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3233\/JAD-170485","article-title":"Kynurenine pathway metabolites in Alzheimer's disease","volume":"60","author":"Giil","year":"2017","journal-title":"J. Alzheimer's Dis. JAD"},{"key":"10.1016\/j.jaut.2022.102911_bib102","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1111\/bph.12230","article-title":"The kynurenine pathway as a therapeutic target in cognitive and neurodegenerative disorders","volume":"169","author":"Stone","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jaut.2022.102911_bib103","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0125109","article-title":"Type I interferon-mediated skewing of the serotonin synthesis is associated with severe disease in systemic lupus erythematosus","volume":"10","author":"Lood","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2022.102911_bib104","first-page":"850","article-title":"Quinolinic acid in patients with systemic lupus erythematosus and neuropsychiatric manifestations","volume":"23","author":"Vogelgesang","year":"1996","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jaut.2022.102911_bib105","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2021-000559","article-title":"Quinolinic acid, a kynurenine\/tryptophan pathway metabolite, associates with impaired cognitive test performance in systemic lupus erythematosus","volume":"8","author":"Anderson","year":"2021","journal-title":"Lupus Sci. Med."},{"key":"10.1016\/j.jaut.2022.102911_bib106","first-page":"16658","article-title":"Role of IL-1\u03b2, IL-6, IL-8 and IFN-\u03b3 in pathogenesis of central nervous system neuropsychiatric systemic lupus erythematous","volume":"8","author":"Wang","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.jaut.2022.102911_bib107","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/acr2.11217","article-title":"Role of serum IL-6 in neuropsychiatric systemic lupus erythematosus","volume":"3","author":"Hirohata","year":"2021","journal-title":"ACR Open Rheumatol."},{"key":"10.1016\/j.jaut.2022.102911_bib108","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186414","article-title":"Evaluation of blood-brain barrier function by quotient alpha2 macroglobulin and its relationship with interleukin-6 and complement component 3 levels in neuropsychiatric systemic lupus erythematosus","volume":"12","author":"Asano","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2022.102911_bib109","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1097\/00004647-200006000-00008","article-title":"Ischemia-induced interleukin-6 as a potential endogenous neuroprotective cytokine against NMDA receptor-mediated excitoxicity in the brain","volume":"20","author":"Ali","year":"2000","journal-title":"J. Cerebr. Blood Flow Metabol."},{"key":"10.1016\/j.jaut.2022.102911_bib110","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.7150\/ijbs.4679","article-title":"Interleukin-6, a major cytokine in the central nervous system","volume":"8","author":"Erta","year":"2012","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.jaut.2022.102911_bib111","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/861231","article-title":"Tumor necrosis factor alpha: a link between neuroinflammation and excitotoxicity","volume":"2014","author":"Olmos","year":"2014","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.jaut.2022.102911_bib112","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.0601-22.2022","article-title":"Elevated TNF-\u03b1 leads to neural circuit instability in the absence of Interferon Regulatory Factor 8","author":"Feinberg","year":"2022","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.jaut.2022.102911_bib113","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jaut.2013.03.002","article-title":"Neuropsychiatric disease in murine lupus is dependent on the TWEAK\/Fn14 pathway","volume":"43","author":"Wen","year":"2013","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2022.102911_bib114","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1177\/0961203315610206","article-title":"Utility of TWEAK to assess neuropsychiatric disease activity in systemic lupus erhytematosus","volume":"25","author":"Fragoso-Loyo","year":"2016","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2022.102911_bib115","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.bbi.2015.12.017","article-title":"Intracerebroventricular administration of TNF-like weak inducer of apoptosis induces depression-like behavior and cognitive dysfunction in non-autoimmune mice","volume":"54","author":"Wen","year":"2016","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jaut.2022.102911_bib116","doi-asserted-by":"crossref","first-page":"10094","DOI":"10.1523\/JNEUROSCI.3382-05.2005","article-title":"Tumor necrosis factor-like weak inducer of apoptosis increases the permeability of the neurovascular unit through nuclear factor-kappa B pathway activation","volume":"25","author":"Polavarapu","year":"2005","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.jaut.2022.102911_bib117","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/1098-1136(200010)32:1<102::AID-GLIA100>3.0.CO;2-U","article-title":"TWEAK stimulation of astrocytes and the proinflammatory consequences","volume":"32","author":"Saas","year":"2000","journal-title":"Glia"},{"key":"10.1016\/j.jaut.2022.102911_bib118","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1742-2094-10-9","article-title":"TWEAK\/Fn14 pathway modulates properties of a human microvascular endothelial cell model of blood brain barrier","volume":"10","author":"Stephan","year":"2013","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jaut.2022.102911_bib119","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1177\/0961203318804895","article-title":"The blood-brain barrier, TWEAK, and neuropsychiatric involvement in human systemic lupus erythematosus and primary Sj\u00f6gren's syndrome","volume":"27","author":"Lauvsnes","year":"2018","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2022.102911_bib120","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2021.155640","article-title":"A review on the role of chemokines in the pathogenesis of systemic lupus erythematosus","volume":"146","author":"Ghafouri-Fard","year":"2021","journal-title":"Cytokine"},{"key":"10.1016\/j.jaut.2022.102911_bib121","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1074-7613(00)80165-X","article-title":"Chemokines: a new classification system and their role in immunity","volume":"12","author":"Zlotnik","year":"2000","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2022.102911_bib122","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1002\/art.22451","article-title":"Interleukin-6 and chemokines in the neuropsychiatric manifestations of systemic lupus erythematosus","volume":"56","author":"Fragoso-Loyo","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2022.102911_bib123","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/978-1-4939-7828-1_14","article-title":"The MRL model: a valuable tool in studies of autoimmunity-brain interactions","volume":"1781","author":"\u0160aki\u0107","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jaut.2022.102911_bib124","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1365-2141.2009.07991.x","article-title":"Advances in the management and understanding of autoimmune lymphoproliferative syndrome (ALPS)","volume":"148","author":"Teachey","year":"2010","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.jaut.2022.102911_bib125","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.mehy.2003.10.009","article-title":"The potential pathogenetic link between peripheral immune activation and the central innate immune response in neuropsychiatric systemic lupus erythematosus","volume":"62","author":"Tomita","year":"2004","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.jaut.2022.102911_bib126","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/s12974-021-02279-9","article-title":"Pyruvate kinase isoform M2 impairs cognition in systemic lupus erythematosus by promoting microglial synaptic pruning via the beta-catenin signaling pathway","volume":"18","author":"Lu","year":"2021","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jaut.2022.102911_bib127","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1177\/096120339700600302","article-title":"Review: behaviour of MRL mice: an animal model of disturbed behaviour in systemic autoimmune disease","volume":"6","author":"Szechtman","year":"1997","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2022.102911_bib128","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1002\/art.24523","article-title":"Time course and nature of brain atrophy in the MRL mouse model of central nervous system lupus","volume":"60","author":"Sled","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2022.102911_bib129","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s12974-015-0423-4","article-title":"Neuropsychiatric systemic lupus erythematosus persists despite attenuation of systemic disease in MRL\/lpr mice","volume":"12","author":"Stock","year":"2015","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jaut.2022.102911_bib130","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1007\/s10067-020-05493-7","article-title":"Lupus animal models and neuropsychiatric implications","volume":"40","author":"Karnopp","year":"2021","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jaut.2022.102911_bib131","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1006\/brbi.1996.0023","article-title":"Anxiety behavior, exploratory behavior, and activity in NZB \u00d7 NZW F1 hybrid mice: role of genotype and autoimmune disease progression","volume":"10","author":"Schrott","year":"1996","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jaut.2022.102911_bib132","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0304-3940(99)00737-5","article-title":"Altered levels of neuropeptides characterize the brain of lupus prone mice","volume":"275","author":"Bracci-Laudiero","year":"1999","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jaut.2022.102911_bib133","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0021-9975(08)80122-3","article-title":"Clinical neurology and brain histopathology in NZB\/NZW F1 lupus mice","volume":"102","author":"Kier","year":"1990","journal-title":"J. Comp. Pathol."},{"key":"10.1016\/j.jaut.2022.102911_bib134","first-page":"443","article-title":"Abnormal increase of neuronal precursor cells and exacerbated neuroinflammation in the corpus callosum in murine model of systemic lupus erythematosus","volume":"34","author":"Leung","year":"2016","journal-title":"Restor. Neurol. Neurosci."},{"key":"10.1016\/j.jaut.2022.102911_bib135","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0006-8993(90)91737-2","article-title":"Brain abnormalities in immune defective mice","volume":"532","author":"Sherman","year":"1990","journal-title":"Brain Res."},{"key":"10.1016\/j.jaut.2022.102911_bib136","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/B978-0-12-394299-9.00004-7","article-title":"Mapping lupus susceptibility genes in the NZM2410 mouse model","volume":"115","author":"Morel","year":"2012","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.jaut.2022.102911_bib137","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4049\/jimmunol.1101686","article-title":"Myeloid dendritic cells from B6.NZM Sle1\/Sle2\/Sle3 lupus-prone mice express an IFN signature that precedes disease onset","volume":"189","author":"Sriram","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2022.102911_bib138","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jaut.2018.08.005","article-title":"Lipocalin-2 is a pathogenic determinant and biomarker of neuropsychiatric lupus","volume":"96","author":"V Mike","year":"2019","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2022.102911_bib139","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1084\/jem.148.5.1198","article-title":"Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains","volume":"148","author":"Andrews","year":"1978","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jaut.2022.102911_bib140","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3109\/08916939309079229","article-title":"Morphological analysis of autoimmune disease in Mrl-lpr, Yaa male mice with rapidly progressive systemic lupus erythematosus","volume":"14","author":"Suzuka","year":"1993","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jaut.2022.102911_bib141","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jneuroim.2003.10.052","article-title":"B and T cells in the brains of autoimmune mice","volume":"146","author":"Zameer","year":"2004","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jaut.2022.102911_bib142","doi-asserted-by":"crossref","first-page":"5548","DOI":"10.4049\/jimmunol.1400122","article-title":"Caspase-8 acts as a molecular rheostat to limit RIPK1- and MyD88-mediated dendritic cell activation","volume":"192","author":"Cuda","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2022.102911_bib143","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3389\/fimmu.2020.00230","article-title":"A novel microglia-specific transcriptional signature correlates with behavioral deficits in neuropsychiatric lupus","volume":"11","author":"Makinde","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2022.102911_bib144","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.bbi.2021.02.010","article-title":"Lupus-prone B6.Nba2 male and female mice display anti-DWEYS reactivity and a neuropsychiatric phenotype","volume":"94","author":"Browne","year":"2021","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jaut.2022.102911_bib145","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1038\/s41467-020-15224-w","article-title":"Lupus autoantibodies act as positive allosteric modulators at GluN2A-containing NMDA receptors and impair spatial memory","volume":"11","author":"Chan","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jaut.2022.102911_bib146","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1002\/art.23399","article-title":"Association of cerebrospinal fluid anti\u2013NR2 glutamate receptor antibodies with diffuse neuropsychiatric systemic lupus erythematosus","volume":"58","author":"Arinuma","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2022.102911_bib147","doi-asserted-by":"crossref","first-page":"18569","DOI":"10.1073\/pnas.1006980107","article-title":"Neurotoxic lupus autoantibodies alter brain function through two distinct mechanisms","volume":"107","author":"Faust","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jaut.2022.102911_bib148","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1084\/jem.20180776","article-title":"Lupus antibodies induce behavioral changes mediated by microglia and blocked by ACE inhibitors","volume":"215","author":"Nestor","year":"2018","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jaut.2022.102911_bib149","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/nm1101-1189","article-title":"A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus","volume":"7","author":"DeGiorgio","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.jaut.2022.102911_bib150","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.immuni.2004.07.011","article-title":"Cognition and immunity: antibody impairs memory","volume":"21","author":"Kowal","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2022.102911_bib151","doi-asserted-by":"crossref","first-page":"19854","DOI":"10.1073\/pnas.0608397104","article-title":"Human lupus autoantibodies against NMDA receptors mediate cognitive impairment","volume":"103","author":"Kowal","year":"2006","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jaut.2022.102911_bib152","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1073\/pnas.0510055103","article-title":"Immunity and behavior: antibodies alter emotion","volume":"103","author":"Huerta","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jaut.2022.102911_bib153","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0197-4580(00)00259-1","article-title":"Cortical alterations of angiotensin converting enzyme, angiotensin II and AT1 receptor in Alzheimer's dementia","volume":"22","author":"Savaskan","year":"2001","journal-title":"Neurobiol. Aging"},{"issue":"Suppl 1","key":"10.1016\/j.jaut.2022.102911_bib154","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1038\/sj.gene.6363907","article-title":"Association of angiotensin-converting enzyme polymorphisms with systemic lupus erythematosus and nephritis: analysis of 644 SLE families","volume":"3","author":"Parsa","year":"2002","journal-title":"Gene Immun."},{"key":"10.1016\/j.jaut.2022.102911_bib155","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1177\/0961203311418268","article-title":"Angiotensin-converting enzyme (ACE) serum levels and gene polymorphism in Egyptian patients with systemic lupus erythematosus","volume":"21","author":"Abbas","year":"2012","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2022.102911_bib156","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1177\/1470320312459979","article-title":"Association between the angiotensin-converting enzyme insertion\/deletion polymorphism and susceptibility to systemic lupus erythematosus: a meta-analysis","volume":"14","author":"Lee","year":"2013","journal-title":"J. Renin-Angiotensin-Aldosterone Syst. JRAAS"},{"key":"10.1016\/j.jaut.2022.102911_bib157","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1177\/1533317507309803","article-title":"Angiotensin converting enzyme inhibitors and cognitive and functional decline in patients with Alzheimer's disease: an observational study","volume":"23","author":"Hajjar","year":"2008","journal-title":"Am. J. Alzheimer's Dis. Other Dementias"},{"key":"10.1016\/j.jaut.2022.102911_bib158","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1111\/jgs.12415","article-title":"Angiotensin-Converting Enzyme Inhibitors and Alzheimer's Disease Progression in Older Adults: results from the R\u00e9seau sur la Maladie d'Alzheimer Fran\u00e7ais Cohort","volume":"61","author":"Soto","year":"2013","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.jaut.2022.102911_bib159","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1212\/WNL.0b013e3182a35228","article-title":"Antihypertensive drugs decrease risk of Alzheimer disease: Ginkgo evaluation of memory study","volume":"81","author":"Yasar","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2022.102911_bib160","doi-asserted-by":"crossref","first-page":"9646","DOI":"10.1007\/s11357-014-9646-z","article-title":"ACE polymorphism and use of ACE inhibitors: effects on memory performance","volume":"36","author":"Schuch","year":"2014","journal-title":"Age (Omaha)"},{"key":"10.1016\/j.jaut.2022.102911_bib161","doi-asserted-by":"crossref","first-page":"386","DOI":"10.2174\/1567205014666171016101816","article-title":"Pharmacogenetics of angiotensin-converting enzyme inhibitors in patients with Alzheimer's disease dementia","volume":"15","author":"de Oliveira","year":"2018","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.jaut.2022.102911_bib162","doi-asserted-by":"crossref","first-page":"595","DOI":"10.3233\/JAD-131694","article-title":"Effects of centrally acting angiotensin converting enzyme inhibitors on functional decline in patients with Alzheimer's disease","volume":"40","author":"O'Caoimh","year":"2014","journal-title":"J. Alzheim. Dis."},{"key":"10.1016\/j.jaut.2022.102911_bib163","first-page":"129","article-title":"Design, synthesis, and antihypertensive activity of curcumin-inspired compounds via ACE inhibition and vasodilation, along with a bioavailability study for possible benefit in cardiovascular diseases","volume":"10","author":"Zhuang","year":"2016","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.jaut.2022.102911_bib164","doi-asserted-by":"crossref","first-page":"876","DOI":"10.3390\/ijms19030876","article-title":"Within the brain: the renin angiotensin system","volume":"19","author":"Jackson","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jaut.2022.102911_bib165","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3389\/fnagi.2017.00129","article-title":"Brain renin-angiotensin system and microglial polarization: implications for aging and neurodegeneration","volume":"9","author":"Labandeira-Garcia","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.jaut.2022.102911_bib166","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3390\/ph14020166","article-title":"Losartan improves memory, neurogenesis and cell motility in transgenic Alzheimer's mice","volume":"14","author":"Drews","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.jaut.2022.102911_bib167","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1471-4159.2006.04339.x","article-title":"Neuroprotective role of bradykinin because of the attenuation of pro-inflammatory cytokine release from activated microglia","volume":"101","author":"Noda","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jaut.2022.102911_bib168","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/S0024-3205(02)02449-9","article-title":"Expression and function of bradykinin receptors in microglia","volume":"72","author":"Noda","year":"2003","journal-title":"Life Sci."},{"key":"10.1016\/j.jaut.2022.102911_bib169","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ejphar.2006.06.074","article-title":"Kinins and neuroinflammation: dual effect on prostaglandin synthesis","volume":"546","author":"Levant","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jaut.2022.102911_bib170","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2017.00082","article-title":"Involvement of the bradykinin B1 receptor in microglial activation: in vitro and in vivo studies","volume":"8","author":"Asraf","year":"2017","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.jaut.2022.102911_bib171","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1080\/14397595.2018.1508801","article-title":"Anti-ribosomal P protein antibodies influence mortality of patients with diffuse psychiatric\/neuropsychological syndromes in systemic lupus erythematous involving a severe form of the disease","volume":"29","author":"Arinuma","year":"2019","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.jaut.2022.102911_bib172","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1056\/NEJM198707303170503","article-title":"Association between lupus psychosis and anti-ribosomal P protein antibodies","volume":"317","author":"Bonfa","year":"1987","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2022.102911_bib173","doi-asserted-by":"crossref","first-page":"46","DOI":"10.4236\/ojra.2015.52009","article-title":"Pathogenesis of neuropsychiatric syndromes of systemic lupus erythematosus","volume":"5","author":"Yoshio","year":"2015","journal-title":"Open J. Rheumatol. Autoimmune Dis."},{"key":"10.1016\/j.jaut.2022.102911_bib174","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1002\/art.39081","article-title":"Pathogenicity of lupus anti-ribosomal P antibodies: role of cross-reacting neuronal surface P antigen in glutamatergic transmission and plasticity in a mouse model","volume":"67","author":"Segovia-Miranda","year":"2015","journal-title":"Arthritis Rheumatol. (Hoboken, N.J.)"},{"key":"10.1016\/j.jaut.2022.102911_bib175","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1084\/jem.20071285","article-title":"Antiribosomal-P autoantibodies from psychiatric lupus target a novel neuronal surface protein causing calcium influx and apoptosis","volume":"204","author":"Matus","year":"2007","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jaut.2022.102911_bib176","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/art.38900","article-title":"Anti-ribosomal P protein autoantibodies from patients with neuropsychiatric lupus impair memory in mice","volume":"67","author":"Bravo-Zehnder","year":"2015","journal-title":"Arthritis Rheumatol. (Hoboken, N.J.)"},{"key":"10.1016\/j.jaut.2022.102911_bib177","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.jaut.2008.09.002","article-title":"Anti-P ribosomal antibodies induce defect in smell capability in a model of CNS -SLE (depression)","volume":"31","author":"Katzav","year":"2008","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2022.102911_bib178","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/nan.12180","article-title":"Mice with experimental antiphospholipid syndrome display hippocampal dysfunction and a reduction of dendritic complexity in hippocampal CA1 neurones","volume":"41","author":"Frauenknecht","year":"2015","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.jaut.2022.102911_bib179","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.1007\/s00429-018-1699-9","article-title":"Decreased hippocampal cell proliferation in mice with experimental antiphospholipid syndrome","volume":"223","author":"Frauenknecht","year":"2018","journal-title":"Brain Struct. Funct."},{"key":"10.1016\/j.jaut.2022.102911_bib180","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jneuroim.2014.04.003","article-title":"Antibody-specific behavioral effects: intracerebroventricular injection of antiphospholipid antibodies induces hyperactive behavior while anti-ribosomal-P antibodies induces depression and smell deficits in mice","volume":"272","author":"Katzav","year":"2014","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jaut.2022.102911_bib181","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.imbio.2012.06.011","article-title":"Neurological impairment in experimental antiphospholipid syndrome is associated with increased ligand binding to hippocampal and cortical serotonergic 5-HT1A receptors","volume":"218","author":"Frauenknecht","year":"2013","journal-title":"Immunobiology"},{"key":"10.1016\/j.jaut.2022.102911_bib182","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2018-000281","article-title":"Elevation of serum anti-glucose-regulated protein 78 antibodies in neuropsychiatric systemic lupus erythematosus","volume":"5","author":"Matsueda","year":"2018","journal-title":"Lupus Sci. Med."},{"key":"10.1016\/j.jaut.2022.102911_bib183","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aai9111","article-title":"Glucose-regulated protein 78 autoantibody associates with blood-brain barrier disruption in neuromyelitis optica","volume":"9","author":"Shimizu","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jaut.2022.102911_bib184","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011124","article-title":"Anti-alpha-internexin autoantibody from neuropsychiatric lupus induce cognitive damage via inhibiting axonal elongation and promote neuron apoptosis","volume":"5","author":"Lu","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2022.102911_bib185","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.clim.2017.11.006","article-title":"Novel anti-suprabasin antibodies may contribute to the pathogenesis of neuropsychiatric systemic lupus erythematosus","volume":"193","author":"Ichinose","year":"2018","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jaut.2022.102911_bib186","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/nature22821","article-title":"Microglia-dependent synapse loss in type I interferon-mediated lupus","volume":"546","author":"Bialas","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2022.102911_bib187","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1007\/s10067-017-3811-6","article-title":"Pristane-induced lupus: considerations on this experimental model","volume":"36","author":"Freitas","year":"2017","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jaut.2022.102911_bib188","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0217190","article-title":"Downregulation of hippocampal NR2A\/2B subunits related to cognitive impairment in a pristane-induced lupus BALB\/c mice","volume":"14","author":"Luciano-Jaramillo","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2022.102911_bib189","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1007\/s10067-022-06094-2","article-title":"Higher IgG level correlated with vitamin D receptor in the hippocampus of a pristane-induced lupus model","volume":"41","author":"Karnopp","year":"2022","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jaut.2022.102911_bib190","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.597966","article-title":"Intestinal microbes in autoimmune and inflammatory disease","volume":"11","author":"Wu","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2022.102911_bib191","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S1474-4422(19)30356-4","article-title":"The gut microbiome in neurological disorders","volume":"19","author":"Cryan","year":"2020","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jaut.2022.102911_bib192","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12974-020-1705-z","article-title":"The progress of gut microbiome research related to brain disorders","volume":"17","author":"Zhu","year":"2020","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jaut.2022.102911_bib193","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.698172","article-title":"The microbiota-gut-brain Axis in Health and disease and its implications for translational research","volume":"15","author":"Schachtle","year":"2021","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.jaut.2022.102911_bib194","article-title":"Microbiota-gut-brain axis: interaction of gut microbes and their metabolites with host epithelial barriers","volume":"30","author":"Bhattarai","year":"2018","journal-title":"Neuro Gastroenterol. Motil."},{"key":"10.1016\/j.jaut.2022.102911_bib195","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1179\/1476830515Y.0000000007","article-title":"Isovaleric acid in stool correlates with human depression","volume":"19","author":"Szczesniak","year":"2016","journal-title":"Nutr. Neurosci."},{"key":"10.1016\/j.jaut.2022.102911_bib196","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20194871","article-title":"Recent advances in our understanding of the link between the intestinal microbiota and systemic lupus erythematosus","volume":"20","author":"Kim","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jaut.2022.102911_bib197","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s13075-020-02264-2","article-title":"Caution in studying and interpreting the lupus metabolome","volume":"22","author":"Zhang","year":"2020","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2022.102911_bib198","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s41927-021-00190-7","article-title":"Association of lipoproteins and thyroid hormones with cognitive dysfunction in patients with systemic lupus erythematosus","volume":"5","author":"Lu","year":"2021","journal-title":"BMC Rheumatol."},{"key":"10.1016\/j.jaut.2022.102911_bib199","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.3389\/fimmu.2020.01027","article-title":"T cell metabolism: a new perspective on Th17\/Treg cell imbalance in systemic lupus erythematosus","volume":"11","author":"Shan","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2022.102911_bib200","series-title":"WILEY 111 RIVER ST, HOBOKEN 07030-5774, NJ USA","article-title":"Role of protein tyrosine phosphatase 1B (PTP1B) in Endothelial-to-Mesenchymal Transition (EndoMT) promoted by inflammation: implications for SLE","author":"Romo-Tena","year":"2020"},{"key":"10.1016\/j.jaut.2022.102911_bib201","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.semarthrit.2019.04.006","article-title":"Metabolism as a key regulator in the pathogenesis of systemic lupus erythematosus","volume":"48","author":"Takeshima","year":"2019","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.jaut.2022.102911_bib202","article-title":"ROS generation in microglia: understanding oxidative stress and inflammation in neurodegenerative disease","volume":"9","author":"Simpson","year":"2020","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.jaut.2022.102911_bib203","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/s12974-017-0978-3","article-title":"Effectors of Th1 and Th17 cells act on astrocytes and augment their neuroinflammatory properties","volume":"14","author":"Prajeeth","year":"2017","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jaut.2022.102911_bib204","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1177\/0961203318796293","article-title":"Vitamin D in SLE: a role in pathogenesis and fatigue? A review of the literature","volume":"27","author":"Nguyen","year":"2018","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2022.102911_bib205","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1177\/0961203316631630","article-title":"Insomnia symptoms, perceived stress and coping strategies in patients with systemic lupus erythematosus","volume":"25","author":"Palagini","year":"2016","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2022.102911_bib206","doi-asserted-by":"crossref","first-page":"4067","DOI":"10.1111\/febs.13412","article-title":"The dynamic blood-brain barrier","volume":"282","author":"Keaney","year":"2015","journal-title":"FEBS J."},{"key":"10.1016\/j.jaut.2022.102911_bib207","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/4576012","article-title":"Blood-brain barrier disruption induced by chronic sleep loss: low-grade inflammation may Be the link","volume":"2016","author":"Hurtado-Alvarado","year":"2016","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.jaut.2022.102911_bib208","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2174\/15672026113109990002","article-title":"REM sleep loss and recovery regulates blood-brain barrier function","volume":"10","author":"Gomez-Gonzalez","year":"2013","journal-title":"Curr. Neurovascular Res."},{"key":"10.1016\/j.jaut.2022.102911_bib209","doi-asserted-by":"crossref","first-page":"14697","DOI":"10.1523\/JNEUROSCI.2111-14.2014","article-title":"Sleep restriction impairs blood-brain barrier function","volume":"34","author":"He","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jaut.2022.102911_bib210","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2020.104944","article-title":"Microglia dynamics in sleep\/wake states and in response to sleep loss","volume":"143","author":"Deurveilher","year":"2021","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.jaut.2022.102911_bib211","doi-asserted-by":"crossref","DOI":"10.1136\/ard-2022-222566","article-title":"Pathogenic neuropsychiatric effect of stress-induced microglial interleukin 12\/23 axis in systemic lupus erythematosus","author":"Abe","year":"2022","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2022.102911_bib212","doi-asserted-by":"crossref","first-page":"5263","DOI":"10.1523\/JNEUROSCI.3981-16.2017","article-title":"Sleep loss promotes astrocytic phagocytosis and microglial activation in mouse cerebral cortex","volume":"37","author":"Bellesi","year":"2017","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jaut.2022.102911_bib213","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/2397698","article-title":"Association of melatonin pathway gene's single-nucleotide polymorphisms with systemic lupus erythematosus in a Chinese population","volume":"2019","author":"Wang","year":"2019","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.jaut.2022.102911_bib214","doi-asserted-by":"crossref","first-page":"273","DOI":"10.5152\/balkanmedj.2013.8064","article-title":"Decreased daily melatonin levels in women with systemic lupus erythematosus - a short report","volume":"30","author":"Robeva","year":"2013","journal-title":"Balkan Med. J."},{"key":"10.1016\/j.jaut.2022.102911_bib215","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1080\/20009666.2021.1956049","article-title":"Vitamin D and Lupus: are we doing enough?","volume":"11","author":"V Chiruvolu","year":"2021","journal-title":"J. Community Hosp. Intern. Med. Perspect."},{"key":"10.1016\/j.jaut.2022.102911_bib216","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2020.105595","article-title":"Daily and seasonal mitochondrial protection: unraveling common possible mechanisms involving vitamin D and melatonin","volume":"199","author":"Mocayar Maron","year":"2020","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jaut.2022.102911_bib217","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1038\/mp.2013.101","article-title":"Brain-reactive IgG correlates with autoimmunity in mothers of a child with an autism spectrum disorder","volume":"18","author":"Brimberg","year":"2013","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.jaut.2022.102911_bib218","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1177\/0961203314541691","article-title":"Neurodevelopmental disorders in children born to mothers with systemic lupus erythematosus","volume":"23","author":"Vinet","year":"2014","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2022.102911_bib219","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.3389\/fimmu.2019.01129","article-title":"Maternal antibody and ASD: clinical data and animal models","volume":"10","author":"Gata-Garcia","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2022.102911_bib220","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1002\/art.39320","article-title":"Increased risk of autism spectrum disorders in children born to women with systemic lupus erythematosus: results from a large population-based cohort","volume":"67","author":"Vinet","year":"2015","journal-title":"Arthritis Rheumatol. (Hoboken, N.J.)"},{"key":"10.1016\/j.jaut.2022.102911_bib221","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1007\/s10803-020-04400-y","article-title":"Maternal systemic lupus erythematosus, rheumatoid arthritis, and risk for autism spectrum disorders in offspring: a meta-analysis","volume":"50","author":"Zhu","year":"2020","journal-title":"J. Autism Dev. Disord."},{"key":"10.1016\/j.jaut.2022.102911_bib222","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1001\/archpedi.157.4.397","article-title":"Effects of mothers' autoimmune disease during pregnancy on learning disabilities and hand preference in their children","volume":"157","author":"Ross","year":"2003","journal-title":"Arch. Pediatr. Adolesc. Med."},{"key":"10.1016\/j.jaut.2022.102911_bib223","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1191\/0961203304lu2018oa","article-title":"Neuropsychological development of children born to patients with systemic lupus erythematosus","volume":"13","author":"Neri","year":"2004","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2022.102911_bib224","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1177\/0961203306071005","article-title":"Impact of in utero environment on the offspring of lupus patients","volume":"15","author":"Tincani","year":"2006","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2022.102911_bib225","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nm.1892","article-title":"Neurotoxic autoantibodies mediate congenital cortical impairment of offspring in maternal lupus","volume":"15","author":"Lee","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.jaut.2022.102911_bib226","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1084\/jem.20111986","article-title":"Female mouse fetal loss mediated by maternal autoantibody","volume":"209","author":"Wang","year":"2012","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jaut.2022.102911_bib227","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1126\/science.aad0314","article-title":"The maternal interleukin-17a pathway in mice promotes autism-like phenotypes in offspring","volume":"351","author":"Choi","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.jaut.2022.102911_bib228","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1177\/0961203315622821","article-title":"Cyclophosphamide in combination with glucocorticoids for severe neuropsychiatric systemic lupus erythematosus: a retrospective, observational two-centre study","volume":"25","author":"Fanouriakis","year":"2016","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2022.102911_bib229","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1136\/ard.2006.057885","article-title":"Efficacy of rituximab (anti-CD20) for refractory systemic lupus erythematosus involving the central nervous system","volume":"66","author":"Tokunaga","year":"2007","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2022.102911_bib230","article-title":"Neuropsychiatric systemic lupus erythematosus: a 2021 update on diagnosis, management, and current challenges","volume":"13","author":"Sarwar","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.jaut.2022.102911_bib231","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/S0028-3908(01)00143-5","article-title":"NMDA antagonists produce site-selective impairment of accuracy in a delayed nonmatch-to-sample task in rats","volume":"41","author":"Willmore","year":"2001","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jaut.2022.102911_bib232","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.semarthrit.2011.02.005","article-title":"Memantine in systemic lupus erythematosus: a randomized, double-blind placebo-controlled trial","volume":"41","author":"Petri","year":"2011","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.jaut.2022.102911_bib233","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1601-5215.2009.00415.x","article-title":"Effects of N-acetylcysteine on substance use in bipolar disorder: a randomised placebo-controlled clinical trial","volume":"21","author":"Bernardo","year":"2009","journal-title":"Acta Neuropsychiatr."},{"key":"10.1016\/j.jaut.2022.102911_bib234","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.biopsych.2008.04.022","article-title":"N-acetyl cysteine for depressive symptoms in bipolar disorder--a double-blind randomized placebo-controlled trial","volume":"64","author":"Berk","year":"2008","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.jaut.2022.102911_bib235","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/art.37893","article-title":"Attention deficit and hyperactivity disorder scores are elevated and respond to N-acetylcysteine treatment in patients with systemic lupus erythematosus","volume":"65","author":"Garcia","year":"2013","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2022.102911_bib236","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.semarthrit.2010.08.001","article-title":"Neuropsychiatric syndromes in systemic lupus erythematosus: a meta-analysis","volume":"41","author":"Unterman","year":"2011","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.jaut.2022.102911_bib237","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nn.3599","article-title":"Identification of a unique TGF-\u03b2\u2013dependent molecular and functional signature in microglia","volume":"17","author":"Butovsky","year":"2014","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.jaut.2022.102911_bib238","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13024-019-0346-0","article-title":"Organotypic brain slice cultures to model neurodegenerative proteinopathies","volume":"14","author":"Croft","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.jaut.2022.102911_bib239","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/jmri.25538","article-title":"Brain morphology and cortical thickness variations in systemic lupus erythematosus patients: differences among neurological, psychiatric, and nonneuropsychiatric manifestations","volume":"46","author":"Zimmermann","year":"2017","journal-title":"J. Magn. Reson. Imag."},{"key":"10.1016\/j.jaut.2022.102911_bib240","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.nicl.2014.07.001","article-title":"Diminished white matter integrity in patients with systemic lupus erythematosus","volume":"5","author":"Schmidt-Wilcke","year":"2014","journal-title":"NeuroImage Clin."},{"key":"10.1016\/j.jaut.2022.102911_bib241","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1177\/0961203313511556","article-title":"In vivo evaluation of brain damage in the course of systemic lupus erythematosus using magnetic resonance spectroscopy, perfusion-weighted and diffusion-tensor imaging","volume":"23","author":"Zimny","year":"2014","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2022.102911_bib242","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1177\/0961203316636471","article-title":"Impaired diffusion tensor imaging findings in the corpus callosum and cingulum may underlie impaired learning and memory abilities in systemic lupus erythematosus","volume":"25","author":"Shapira-Lichter","year":"2016","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2022.102911_bib243","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/art.21591","article-title":"Diagnostic value of single-photon-emission computed tomography in severe central nervous system involvement of systemic lupus erythematosus: a case-control study","volume":"53","author":"Zhang","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2022.102911_bib244","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1007\/s100670200126","article-title":"Abnormal regional cerebral blood flow found by technetium-99m ethyl cysteinate dimer brain single photon emission computed tomography in systemic lupus erythematosus patients with normal brain MRI findings","volume":"21","author":"Chen","year":"2002","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jaut.2022.102911_bib245","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1191\/0961203303lu470oa","article-title":"Cerebral hypoperfusion detected by SPECT in patients with systemic lupus erythematosus is related to clinical activity and cumulative tissue damage","volume":"12","author":"L\u00f3pez-Longo","year":"2003","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2022.102911_bib246","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2014-000074","article-title":"Brain metabolism and autoantibody titres predict functional impairment in systemic lupus erythematosus","volume":"2","author":"Mackay","year":"2015","journal-title":"Lupus Sci. Med."},{"key":"10.1016\/j.jaut.2022.102911_bib247","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1002\/art.24523","article-title":"Time course and nature of brain atrophy in the MRL mouse model of central nervous system lupus","volume":"60","author":"Sled","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2022.102911_bib248","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0165-5728(98)00085-X","article-title":"Progressive atrophy of pyramidal neuron dendrites in autoimmune MRL-lpr mice","volume":"87","author":"\u0160aki\u0107","year":"1998","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jaut.2022.102911_bib249","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jneuroim.2006.06.023","article-title":"Distribution and prevalence of leukocyte phenotypes in brains of lupus-prone mice","volume":"179","author":"Ma","year":"2006","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jaut.2022.102911_bib250","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0165-5728(01)00412-X","article-title":"Immunoglobulin binding to brain in autoimmune mice","volume":"120","author":"Zameer","year":"2001","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jaut.2022.102911_bib251","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/0031-9384(94)90309-3","article-title":"Disturbed emotionality in autoimmune MRL-lpr mice","volume":"56","author":"\u0160aki\u0107","year":"1994","journal-title":"Physiol. Behav."}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841122001196?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841122001196?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:33:11Z","timestamp":1760257991000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841122001196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":251,"alternative-id":["S0896841122001196"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2022.102911","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cognitive dysfunction in SLE: An understudied clinical manifestation","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2022.102911","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102911"}}